Literature DB >> 28669890

Detection of anti-glutamic acid decarboxylase antibodies in immunoglobulin products.

Tukisa D Smith1, Charlotte Cunningham-Rundles2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28669890      PMCID： PMC5897895          DOI： 10.1016/j.jaip.2017.04.042

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  11 in total

1.  Atypical C-ANCA following high dose intravenous immunoglobulin.

Authors:  S Jolles; S Deacock; W Turnbull; R Silvestrini; C Bunn; P White; M Ward
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

Review 2.  Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.

Authors:  M D Kazatchkine; S V Kaveri
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

3.  Human anti-FcepsilonRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid.

Authors:  M P Horn; T Gerster; B Ochensberger; T Derer; F Kricek; M H Jouvin; J P Kinet; T Tschernig; M Vogel; B M Stadler; S M Miescher
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

4.  The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.

Authors:  M C Dalakas; M Fujii; M Li; B McElroy
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

5.  False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin.

Authors:  F de Beer; M W J Schreurs; E M J Foncke
Journal:  Clin Neurol Neurosurg       Date:  2009-05-12       Impact factor: 1.876

6.  Intravenous immunoglobulin contains detectable amounts of antiphospholipid antibodies.

Authors:  P Stratta; C Canavese; P C Schinco; B Montaruli; L Giorda; P Bessone; S Ferrero; A Grill; G Piccoli
Journal:  Br J Haematol       Date:  1997-03       Impact factor: 6.998

7.  Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations.

Authors:  W Hao; C Davis; T Daniels; C S Hampe; A Lernmark
Journal:  Transfus Med       Date:  1999-12       Impact factor: 2.019

Review 8.  Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.

Authors:  Jordan S Orange; Elham M Hossny; Catherine R Weiler; Mark Ballow; Melvin Berger; Francisco A Bonilla; Rebecca Buckley; Javier Chinen; Yehia El-Gamal; Bruce D Mazer; Robert P Nelson; Dhavalkumar D Patel; Elizabeth Secord; Ricardo U Sorensen; Richard L Wasserman; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

Review 9.  Immunology of stiff person syndrome and other GAD-associated neurological disorders.

Authors:  Harry Alexopoulos; Marinos C Dalakas
Journal:  Expert Rev Clin Immunol       Date:  2013-11       Impact factor: 4.473

10.  Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.

Authors:  J Kim; M Namchuk; T Bugawan; Q Fu; M Jaffe; Y Shi; H J Aanstoot; C W Turck; H Erlich; V Lennon; S Baekkeskov
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307
View more
  4 in total

1.  Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity.

Authors:  Thomas Grüter; Anthonina Ott; Wolfgang Meyer; Sven Jarius; Markus Kinner; Jeremias Motte; Kalliopi Pitarokoili; Ralf Gold; Lars Komorowski; Ilya Ayzenberg
Journal:  J Neurol       Date:  2019-11-14       Impact factor: 4.849

2.  Heidenhain variant sporadic Creutzfeldt-Jakob disease diagnosed as an autoimmune encephalitis due to a false-positive GAD autoantibody.

Authors:  Nicolás Urriola; Kavie Soosapilla; Geoffrey Herkes; Joseph Nogajski
Journal:  BMJ Case Rep       Date:  2019-05-06

3.  Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C.

Authors:  Peter D Burbelo; Riccardo Castagnoli; Chisato Shimizu; Ottavia M Delmonte; Kerry Dobbs; Valentina Discepolo; Andrea Lo Vecchio; Alfredo Guarino; Francesco Licciardi; Ugo Ramenghi; Emma Rey-Jurado; Cecilia Vial; Gian Luigi Marseglia; Amelia Licari; Daniela Montagna; Camillo Rossi; Gina A Montealegre Sanchez; Karyl Barron; Blake M Warner; John A Chiorini; Yazmin Espinosa; Loreani Noguera; Lesia Dropulic; Meng Truong; Dana Gerstbacher; Sayonara Mató; John Kanegaye; Adriana H Tremoulet; Eli M Eisenstein; Helen C Su; Luisa Imberti; Maria Cecilia Poli; Jane C Burns; Luigi D Notarangelo; Jeffrey I Cohen
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

4.  Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice.

Authors:  Maria M Dimitriadou; Haris Alexopoulos; Sofia Akrivou; Eleni Gola; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.